cas 161493-94-3|| where to buy (1-Methyl-1H-imidazol-2-yl)methanamine hydrochloride

Product Name:(1-Methyl-1H-imidazol-2-yl)methanamine hydrochloride

IUPAC Name:1-(1-methyl-1H-imidazol-2-yl)methanamine hydrochloride

Packing Unit	Available Stock	Price($)
CM369826-50mg	in stock	ũũ
CM369826-100mg	in stock	Ǝǜ
CM369826-250mg	in stock	ƿŵƛ
CM369826-500mg	in stock	Ȑƿǜ
CM369826-1g	in stock	ȐǜȐ
CM369826-5g	in stock	ƿƛȐȐ
CM369826-10g	in stock	ƿȺȺƛ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 161493-94-3 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:161493-94-3; Molecular Formula:C5H10ClN3; Melting Point:-; Smiles Code:Cl.CN1C=CN=C1CN; Density:

: Catalog Number:CM369826; Molecular Weight:147.61; Boiling Point:; MDL No:; Storage:

: Imidazoles; Imidazole is an important five-membered nitrogen-containing heterocyclic compound. Among the numerous heterocyclic compounds, imidazole and its derivatives are regarded as a unique and multifaceted scaffold material due to their diverse applications in industrial, organic and pharmaceutical chemistry. Imidazoles interact in different ways with many therapeutic targets, enzymes and receptors in biological systems and thus exhibit a wide range of biological activities. In particular, several imidazoles can be used as clinical drugs to treat various types of cancer with high therapeutic efficacy. Furthermore, imidazoles are one of the most critical segments in the field of anti-covid-19 virus drug discovery due to their ability to interact with active targets in living systems.; Imidazole Manufacturer; As a professional imidazole manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.